AOAH and metabolic dysfunction-associated steatotic liver disease: When we scored MASLD severity based on steatosis, hepatocyte ballooning degeneration, and inflammation, Aoah-/- mice developed more severe MASLD than did Aoah+/+ mice whether the mice were fed NC or HFD (Sheka et al., 2020; Figure 1E).